|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
�����8��,�� |
|
����,������ |
| ��������������� | |
|
������ |
|
������ |
|
���� |
| PubMed | |
|
Article by |
|
Article by |
|
Article by |
�������8����Kaposi�����������������õ��о���״
������, ������, ����
�½�ά�������������ҽԺƤ���� ��³ľ�� 830001
�������8��,�ֳ�ΪKaposi������������,������ȷΪһ��DNA����,����Kaposi�����ķ�������,�䲡������������ϸ����ֳ,ϸ�����ӵĴ��������ü������Ի�������״̬��Ӱ���������Kaposi�����ķ����ͷ�չ����Ŀǰ��ȷ�з��������в���ȷ��
������Ȼ��ѧ����������Ŀ(30160082)
[2] Song J, Ohkura T, Sugimoto M, et al. Human interleukin-6 induces human herpesvirus-8 replication in a body cavity-based lymphoma cell line. J Med Virol, 2002, 68:404-411.
[3] Mori Y, NishimotoN, Ohno M, et al. Human herpesvirus 8-encoded interleukin-6 homologue (viral IL-6) induces endogenous human IL-6 secretion. J Med Virol, 2000,61:332-335.
[4] Klouche M, Brockmeyer N, Knabbe C, et al. Human herpesvirus 8-derived viral IL-6 induces PTX3 expression in Kaposi's sarcoma cells. AIDS, 2002, 16:F9-18.
[5] Nakano K, Isegawa Y, Zou P, et al. Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded vMIP-�� and vMIP-�� induce signal transduction and chemotaxis in monocytic cells. Arch Virol, 2003,148:871-890.
[6] Stine JT, Wood C, Hill M, et al. KSHV-encoded CC chemokine vMIP-�� is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. Blood, 2000, 95:1151-1157.
[7] Masood R, Cesarman E, Smith DL, et al. Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor. Am J Pathol, 2002, 160:23-29.
[8] Burysek L, Yeow WS, Lubyova B, et al. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J Virol, 1999, 73:7334-7342.
[9] Zimring JC, Goodbourn S, Offermann MK. Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J Virol, 1998, 72:701-707.
[10] Lundquist A, Barre B, Bienvenu F, et al. Kaposi sarcoma-associated viral cyclin K overrides cell growth inhibition mediated by oncostatin M through STAT3 inhibition. Blood, 2003, 101:4070-4077.
[11] Ojala PM, Tiainen M, Salven P, et al. Kaposi's sarcoma-associated herpesvirus-encoded v-cyclin triggers apoptosis in cells with high levels of cyclin-dependent kinase 6. Cancer Res, 1999, 59:4984-4989.
[12] Verschuren EW, Klefstrom J, Evan GI, et al. The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo. Cancer Cell, 2002, 2:229-241.
[13] Moore PS, Chang Y. Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis:two sides of the same coin? Annu Rev Microbiol, 2003,57:609-639.
[14] Monini P, Colombini S, Sturzl M, et al. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi' s sarcoma. Blood, 1999, 93:4044-4058.
[15] Coscoy L, Ganem D. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class �� chains by enhancing their endocytosis. Proc Natl Acad Sci USA, 2000, 97:8051-8056.
[16] Barozzi P, Luppi M, Facchetti F, et al. Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat Med,2003, 9:554-561.